Treatment Management of HER2+ Breast Cancer

REAL Alliance Recommendations:

Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Setting

Coming January 2026

REAL Alliance Health Technology Drug Review Recommendations:

Clinician CDA Feedback

Clinical CDA Input

Charitable Registration Number: 13796 9861 RR0001

© Breast Cancer Canada 2025

Twitter Facebook-f Instagram Linkedin

CONTACT US